Fortrea Holdings Inc. has a one year low of $8.16 and a one year high of $40.63. Fortrea ( NASDAQ:FTRE – Get Free Report ) last issued its quarterly earnings results on Monday, March 3rd.

Fortrea Holdings Inc. ( (FTRE)) has released its Q4 earnings. Here is a breakdown of the information Fortrea Holdings Inc. presented to its investors. Discover the Best Stocks and Maximize Your ...

NEW YORK CITY, NY / ACCESS Newswire / March 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions.

Fortrea Holdings Inc. (NASDAQ:FTRE – Get Free Report) has received a consensus rating of “Reduce” from the twelve analysts that are currently covering the stock, MarketBeat Ratings reports.

Ladies and gentlemen, thank you for standing by, and welcome to Fortrea Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being ...

Shares of Fortrea Holdings sank to a new low after the company said it expects revenue to drop this year. The stock fell 31% to a new all-time low of $9.55 in the first half of the trading day.

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Fortrea Holdings Inc (Symbol: FTRE) entered into oversold territory, hitting an RSI reading ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...